ena-STUDY-Candiolo Cancer Institute-16-07-2021-11:50:37:221-264
Temozolomide treatment leads to alterations in mismatch repair genes and can be followed by response to immune checkpoint blockade in colorectal cancer patients
Temozolomide treatment leads to alterations in mismatch repair genes and can be followed by response to immune checkpoint blockade in colorectal cancer patientsONLY CELL LINES DATA were submitted
Temozolomide treatment leads to alterations in mismatch repair genes and can be followed by response to immune checkpoint blockade in colorectal cancer patientsONLY CELL LINES DATA were submitted